流的剪切力通过影响CHOP和GRP78蛋白质来破坏 carotid斑块的稳定
Dong Chen1, Liding Wang2, Tao Jiang3
1Dalian University of Technology, China; Dalian University of Technology Affiliated Central Hospital, China.
概括
低血流剪切力增加GRP78和CHOP的表达,可能会破坏心血管斑块的稳定,增加中风风险. 这突显了动脉样硬化斑块不稳定的关键因素.
科学领域:
- 心血管研究研究心血管研究
- 生物医学工程 生物医学工程
- 分子生物学分子生物学
背景情况:
- 缺血性中风通常是由不稳定的喉动脉样硬化斑块引起的,其中18-25%与斑块破裂有关.
- 斑块稳定性对于患者的预后至关重要,需要准确的方法来评估它.
- 以前的研究将CHOP (C/EBP同源蛋白) 和GRP78 (葡萄糖调节蛋白78) 的表达与斑块稳定性联系起来.
研究的目的:
- 为了研究血液流动剪切力对内皮细胞GRP78和CHOP表达的影响.
- 实证地研究剪切力如何影响人动脉动脉硬化斑块的稳定性.
- 探索血液动力学因素在动脉斑不稳定中的作用.
主要方法:
- 人的静脉内皮细胞受到低,中,高切削力 (4,8,12天/厘米2) 的影响.
- 使用西部斑块和RT-qPCR量化了GRP78和CHOP蛋白和mRNA水平.
- 来自60名患者的斑块被分类为稳定或不稳定,在动脉分叉处测量了剪切力.
主要成果:
- 与中高剪切相比,低剪切力显著提高了内皮细胞中的GRP78和CHOP表达.
- 不稳定的动脉斑块在分叉处表现出明显较低的剪切力,而不是稳定的斑块.
- 与稳定的相比,不稳定的斑块中的GRP78和CHOP表达水平显著更高.
结论:
- 血流剪切力在血管内皮细胞中差异调节GRP78和CHOP的表达.
- 降低的切削力和较低的流体流速与增加的GRP78和CHOP表达相关.
- 升高的GRP78和CHOP可能会诱导内分泌网膜应激,导致状腺斑块不稳定和中风风险.
更多相关视频
13:45A Method to Study the Correlation Between Local Collagen Structure and Mechanical Properties of Atherosclerotic Plaque Fibrous Tissue
Published on: November 11, 2022
2.1K
11:00A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid Endothelium
Published on: June 22, 2010
28.5K
相关概念视频
Formation of the Platelet Plug
5.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.7K
Clot Retraction and Fibrinolysis
5.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
514
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
514
